Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results. Dale KD, Denholm JT. Vaccine 2025;49:126816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dale KD, Denholm JT. Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results. Vaccine 2025;49:126816.
PMID: 39892110